Meditab Specialities Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 7.12 M
- Company Age 28 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 13924.66%
- Profit Growth 4881.91%
- Ebitda -27.10%
- Net Worth 1.87%
- Total Assets 2.50%
About Meditab Specialities
Meditab Specialities Limited (MSL) is a leading Public Limited Indian Non-Government Company incorporated in India on 11 December 1996 and has a history of 28 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Meditab Specialities Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 7.12 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Meditab Specialities Limited India are Girish Zamwar as CFO and Pavan Yadav as Company Secretary. Dinesh Jain, Rajendra Chopra, Anisha Udeshi, and One other member serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U23240MH1996PLC104442
- Company No.
104442
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Dec 1996
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Meditab Specialities?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Mishra  | Managing Director | 21-Oct-2022 | Current |
| Girish Zamwar | CFO | 05-Mar-2020 | Current |
| Pavan Yadav | Company Secretary | 26-Sep-2023 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dinesh Jain | Director | 03-Jan-2019 | Current |
| Anisha Udeshi | Director | 23-Aug-2021 | Current |
| Rajendra Chopra | Additional Director | 11-Nov-2024 | Current |
Financial Performance of Meditab Specialities.
Meditab Specialities Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13924.66% increase. The company also saw a substantial improvement in profitability, with a 4881.91% increase in profit. The company's net worth moved up by a moderate rise of 1.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meditab Specialities?
In 2022, Meditab Specialities had a promoter holding of 100.00%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medispray Laboratories Private LimitedDinesh Jain, Anisha Udeshi and 1 more are mutual person
Goldencross Pharma LimitedDinesh Jain, Rajendra Chopra and 1 more are mutual person
- Cipla Pharmaceuticals Limited
Dinesh Jain, Rajendra Chopra and 1 more are mutual person
- Cipla Digital Health Limited
Dinesh Jain, Rajendra Chopra and 1 more are mutual person
Cipla Pharma And Life Sciences LimitedRajendra Chopra and Anisha Udeshi are mutual person
Jay Precision Pharmaceuticals Private LimitedDinesh Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Meditab Specialities?
Meditab Specialities has a workforce of 126 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meditab Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meditab Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
